Titan Medical Inc
  • Home
  • About
    • Leadership
    • Board of Directors
    • Surgeon Advisory Board
    • Certifications
    • Careers
  • Investors
    • IR Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Enos
    • Titan Living Labs
    • Technology
    • Videos
    • Publications
  • Media
  • Contact
Select Page

Press Releases

Investors

Investors

  • IR Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Special Shareholder Meeting
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • PFIC Statements
  • Stock Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
  • SEDAR
  • Governance
    • Governance at a Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
  • Special Shareholder Meeting
Mar 22, 2023 5:01pm EDT

Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC

Mar 09, 2023 7:30am EST

Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares

Feb 14, 2023 7:30am EST

Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements

Feb 08, 2023 9:15am EST

Titan Medical Provides Corporate Update

Jan 09, 2023 7:30am EST

Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week

Dec 28, 2022 5:01pm EST

Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

Dec 13, 2022 7:30am EST

Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery

Dec 07, 2022 7:30am EST

Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process

Dec 06, 2022 9:10am EST

Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process

Nov 30, 2022 7:30am EST

Titan Medical Announces Commencement of Strategic Review Process

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …38
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

About

Leadership

Board of Directors

Surgeon Advisory Board

Certifications

Careers

Enos System

Technology

Videos

Investors

IR Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
AdvaMed Code of Ethics Certified Logo


Phone

(416) 548-7522



General Inquiries

info@titanmedicalinc.com



Investor Relations

investors@titanmedicalinc.com



Corporate Address

Titan Medical Inc.
76 Berkely Street
Toronto, Ontario M5A 2W7
Canada



USA Address

Titan Medical USA Inc.
6350 Quadrangle Drive, Suite 120
Chapel Hill, NC 27517

  • Titan Living Labs
  • Linkedin